Gabapentin Solution
Product Images NDC 0121-2134

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 0121-2134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clcr (Gaba Os 1)

Clcr (Gaba Os 1)
This text provides an equation for calculating creatinine clearance (CLCr) based on age, weight, and serum creatinine levels. The equation includes a correction factor of 0.85 for female patients, indicating a gender-specific adjustment. By multiplying the age in years by the weight in kilograms, and then multiplying by 772 and the serum creatinine in mg/dL, the CLCr can be calculated.*
FDA Label Image

Structure (Gaba Os 2)

FDA Label Image

Figure 1 (Gaba Os 3)

Figure 1 (Gaba Os 3)
This is a chart showing the mean pain scores during a study that involved a 4-week dose titration period followed by a 4-week fixed dose period. The study compared the effects of placebo versus gabapentin at a dosage of 3600 mg/day on pain levels over the course of 4 weeks.*
FDA Label Image

Figure 2 (Gaba Os 4)

Figure 2 (Gaba Os 4)
This is a table showing the mean pain scores for different treatment conditions over a 3-week dose titration period and a subsequent 4-week fixed dose period. The treatments compared are Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day.*
FDA Label Image

Figure 3 (Gaba Os 5)

FDA Label Image

Figure 4 (Gaba Os 6)

FDA Label Image

Bottle Label Unflavored (Gaba Os 7)

Bottle Label Unflavored (Gaba Os 7)
This is a description of Gabapentin Oral Solution, 250 mg per 5 mL, indicated for prescription use only. The solution comes in a 470 mL bottle and should be dispensed with a Medication Guide to each patient. Each 5 mL of the solution contains 250 mg of Gabapentin. The dosing information should be followed as per the accompanying prescribing information. It is recommended to keep this medication out of reach of children and store it refrigerated between 2°C to 8°C (36°F to 46°F). The product is distributed by PAI Pharma in Greenville, SC.*
FDA Label Image

5ml Lidding Label (Gaba Os 8)

5ml Lidding Label (Gaba Os 8)
This text contains information about a medication called Gabapentin in oral solution form with a concentration of 250 mg per 5 mL. It advises to store the solution refrigerated between 2°C to 8°C (36°F to 46°F) and mentions that the package is child-resistant. The text also includes the manufacturer's code: NOC 0121408705.*
FDA Label Image

6 mL Lidding Label (Gaba Os 9)

6 mL Lidding Label (Gaba Os 9)
This text provides information about a Gabapentin Oral Solution with a concentration of 300 mg per 6 mL. The NDC code for this product is 0121-2134-06. The solution must be stored refrigerated between 2°C to 8°C (36°F to 46°F) and the package is not child-resistant. It is distributed by PAI Pharma and a further reference is made to an insert for additional details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.